196 related articles for article (PubMed ID: 21949845)
1. ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.
Li X; Zhu C; Tu WH; Yang N; Qin H; Sun Z
PLoS One; 2011; 6(9):e25040. PubMed ID: 21949845
[TBL] [Abstract][Full Text] [Related]
2. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
He Y; Mi J; Olson A; Aldahl J; Hooker E; Yu EJ; Le V; Lee DH; Kim WK; Robins DM; Geradts J; Sun Z
Oncogene; 2020 Apr; 39(16):3276-3291. PubMed ID: 32089544
[TBL] [Abstract][Full Text] [Related]
5. hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes.
Huang CY; Beliakoff J; Li X; Lee J; Li X; Sharma M; Lim B; Sun Z
Mol Endocrinol; 2005 Dec; 19(12):2915-29. PubMed ID: 16051670
[TBL] [Abstract][Full Text] [Related]
6. Differential requirement of SWI/SNF for androgen receptor activity.
Marshall TW; Link KA; Petre-Draviam CE; Knudsen KE
J Biol Chem; 2003 Aug; 278(33):30605-13. PubMed ID: 12775722
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.
Yuan H; Young CY; Tian Y; Liu Z; Zhang M; Lou H
Mol Cell Biochem; 2010 Jun; 339(1-2):253-62. PubMed ID: 20148354
[TBL] [Abstract][Full Text] [Related]
9. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
[TBL] [Abstract][Full Text] [Related]
10. Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription.
Hosohata K; Li P; Hosohata Y; Qin J; Roeder RG; Wang Z
Mol Cell Biol; 2003 Oct; 23(19):7019-29. PubMed ID: 12972618
[TBL] [Abstract][Full Text] [Related]
11. A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.
Peng Y; Lee J; Zhu C; Sun Z
J Biol Chem; 2010 Apr; 285(15):11465-75. PubMed ID: 20159969
[TBL] [Abstract][Full Text] [Related]
12. Differential transactivation by the androgen receptor in prostate cancer cells.
Snoek R; Bruchovsky N; Kasper S; Matusik RJ; Gleave M; Sato N; Mawji NR; Rennie PS
Prostate; 1998 Sep; 36(4):256-63. PubMed ID: 9719026
[TBL] [Abstract][Full Text] [Related]
13. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
14. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
[TBL] [Abstract][Full Text] [Related]
15. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
[TBL] [Abstract][Full Text] [Related]
16. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
17. Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor.
Mukhopadhyay NK; Ferdinand AS; Mukhopadhyay L; Cinar B; Lutchman M; Richie JP; Freeman MR; Liu BC
Exp Cell Res; 2006 Nov; 312(19):3782-95. PubMed ID: 17011549
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.
Irvine RA; Ma H; Yu MC; Ross RK; Stallcup MR; Coetzee GA
Hum Mol Genet; 2000 Jan; 9(2):267-74. PubMed ID: 10607837
[TBL] [Abstract][Full Text] [Related]
19. Influence of short polyglutamine tracts and p160 coactivators on the transactivation of the androgen receptor.
Shi XB; Xue L; Shi D; deVere White RW
Cancer Biother Radiopharm; 2011 Apr; 26(2):191-201. PubMed ID: 21539451
[TBL] [Abstract][Full Text] [Related]
20. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
Gao N; Zhang J; Rao MA; Case TC; Mirosevich J; Wang Y; Jin R; Gupta A; Rennie PS; Matusik RJ
Mol Endocrinol; 2003 Aug; 17(8):1484-507. PubMed ID: 12750453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
